Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer’s disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial
Seong‐Ho Koh(Hanyang University Guri Hospital), Kyu‐Yong Lee(Hanyang University Guri Hospital), Jee Hyang Jeong(Ewha Womans University), Sangjae Kim(Polaroid (United States)), Ae Young Lee(Chungnam National University Hospital), Hae Ri Na(Bobath memorial hospital), Hyuk Sung Kwon(Seoul National University), Kyung Won Park(Dong-A University), Jin Se Park(Inje University Haeundae Paik Hospital), Chan‐Nyoung Lee(Korea University Medical Center), Hyun Jeong Han(Kyungdong University), Jee‐Young Lee(Seoul National University), Jae‐Hong Lee(Asan Medical Center), YoungSoon Yang(Veterans Health Service Medical Center), Seong Hye Choi(Inha University), Byeong C. Kim(Chonnam National University Hospital)
Cited by 38
Related Papers
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
|Translational Neurodegeneration|2020|2.5k
Cryptogenic Stroke and High-Risk Patent Foramen Ovale
|Journal of the American College of Cardiology|2018|570
World‐Wide FINGERS Network: A global approach to risk reduction and prevention of dementia
|Alzheimer s & Dementia|2020|516
Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease
|European Journal of Nuclear Medicine and Molecular Imaging|2008|277